783325-25-7

Basic information

• Product Name: (R)-1-BOC-2-(METHYLAMINOMETHYL)-PYRROLIDINE
• Synonyms: (R)-1-BOC-2-(METHYLAMINOMETHYL)-PYRROLIDINE;(R)-N-methyl-1-(1-Bocpyrrolidin-2-yl)methanamine;(R)-tert-butyl 2-((methylamino)methyl)pyrrolidine-1-carboxylate;tert-butyl (2R)-2-[(MethylaMino)Methyl]pyrrolidine-1-carboxylate;(2R)-2-[(Methylamino)methyl]-1-pyrrolidinecarboxylic acid tert-butyl ester;(R)-1-Boc-2-(N-methylaminomethyl)-pyrrolidine
• CAS NO: 783325-25-7
• Molecular Formula: C11H22N2O2
• Molecular Weight: 214.3
• Mol File: 783325-25-7.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 282℃
• Flash Point: 124℃
• Appearance: /
• Density: 1.004
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• CAS DataBase Reference: (R)-1-BOC-2-(METHYLAMINOMETHYL)-PYRROLIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-1-BOC-2-(METHYLAMINOMETHYL)-PYRROLIDINE(783325-25-7)
• EPA Substance Registry System: (R)-1-BOC-2-(METHYLAMINOMETHYL)-PYRROLIDINE(783325-25-7)

Safety Data

• Hazardous Substances Data: 783325-25-7(Hazardous Substances Data)

Usage

General Description

(R)-1-BOC-2-(methylaminomethyl)-pyrrolidine is a chemical compound with a structure containing a pyrrolidine ring and a methylaminomethyl group, both of which are important in organic synthesis and pharmaceutical research. The compound is commonly used in the preparation of chiral molecules and as a precursor for the synthesis of various pharmaceuticals, including potential therapeutic agents. Its BOC (tert-butoxycarbonyl) protecting group plays a crucial role in controlling the reactivity and selectivity of the compound in organic reactions. Overall, (R)-1-BOC-2-(methylaminomethyl)-pyrrolidine is a versatile and important chemical in the field of organic chemistry and pharmaceutical development.

Upstream product

• 37784-17-1 N-(tert-butoxycarbonyl)-D-proline 
• 785825-41-4 2-methylcarbamoyl-pyrrolidine-1-carboxylic acid tert-butyl ester 
• 74-89-5 methylamine 
• 15761-39-4 1-(tert-butoxycarbonyl)-L-proline 

Relevant articles and documents

Novel diamino derivatives of [1,2,4]triazolo[1,5-a][1,3,5]triazine as potent and selective adenosine A2a receptor antagonists

Piperazine derivatives of 2-furanyl[1,2,4]triazolo[1,5-a][1,3,5]triazine have recently been demonstrated to be potent and selective adenosine A 2a receptor antagonists with oral activity in rodent models of Parkinson's disease. We have replaced

TRIAZOLOTRIAZINES AND PYRAZOLOTRIAZINES AND METHODS OF MAKING AND USING THE SAME

The invention is based on the discovery that compounds of formula (I) possess unexpectedly high affinity for the A2a adenosine receptor, and can be useful as antagonists thereof for preventing and/or treating numerous diseases, including Parkinson’s disease. In one embodiment, the invention features a compound of formula I: (I)